Jimenez Says Novartis Poised for Next Growth Phase

Jan. 23 (Bloomberg) -- Novartis AG Chief Executive Officer Joseph Jimenez discusses profitability and Chairman Daniel Vasella's decision to step down from the board of Europe's biggest drugmaker. He talks with Mark Barton on Bloomberg Television's "Countdown." (Source: Bloomberg)

Top Dividend ETFs Brace for Test From Rising Rates
35:34 - Bloomberg Intelligence's Eric Balchunas and Bloomberg's Abigail Doolittle look at how dividend ETFs may be impacted by expected rate increases. They speak on "Bloomberg Markets." (Source: Bloomberg)
  • BHP CEO Is 'Slightly Alarmed' by Trade Protectionism
  • Shiller Sees Trump Regulations as 'Behavioral Economics'
  • Yale's Robert Shiller Sees Room to Run for Trump Bump